Newsfile Corp
16 Nov 2025, 12:45 UTC · 48w ago
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
Impact · against what's priced in
The news is fundamentally negative for Jasper Therapeutics, as it confirms the collapse of multiple clinical pipelines and severe financial instability. While the lawsuit is a further complication, the primary catalyst is the admission of manufacturing failures that undermine the viability of its drug product.
- JSPR−1.00
No priced-in read yet





